Every material Form 8-K CRH filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
CRH plc said its subsidiary CRH America Finance, Inc. has started cash tender offers for Arcosa, Inc. notes and exchange offers for up to $1.0 billion of new CRH America Finance notes, following CRH's acquisition of Arcosa completed October 23, 2026. Arcosa is also soliciting consents to amend the indentures governing those notes, which would eliminate certain covenants, restrictive provisions, events of default and guarantee provisions. The offers are conditioned on proceeds from a concurrent public offering of senior debt by CRH America Finance, guaranteed by CRH plc, and the filing describes this as a refinancing of acquired debt rather than a change in operating results.
Tender offers cover $400 million of 4.375% notes due 2029 and $600 million of 6.875% notes due 2032
Early tender deadline is November 18, 2026; early settlement expected November 20, 2026; offers expire December 4, 2026
Total tender consideration is $983.75 (2029 notes) and $1,035.00 (2032 notes) per $1,000 principal, including a $50 early tender premium
Exchange offers are capped at up to $1,000,000,000 aggregate principal of new CRH America Finance notes guaranteed by CRH plc
CRH reported third quarter 2026 total revenues of $11.4 billion and net income of $1.2 billion, representing a decrease from the prior year due to impairment losses. The company lowered its full-year 2026 guidance for net income and adjusted EBITDA, citing a challenging residential market and inflationary costs, while announcing a new $6 billion share buyback program running through 2030. Additionally, CRH completed its $8.5 billion acquisition of Arcosa on October 23, 2026.
Total revenues for Q3 2026 were $11.4 billion, up 3% year-over-year, while net income declined to $1.2 billion.
Full-year 2026 guidance was revised to net income of $3.1 billion to $3.3 billion and Adjusted EBITDA of $7.8 billion to $8.0 billion.
CRH completed the $8.5 billion acquisition of Arcosa on October 23, 2026.
A new share buyback program of up to $6 billion was authorized, expiring at the end of 2030.
CRH announced on October 23, 2026 that it has completed its acquisition of Arcosa, Inc., a U.S. aggregates and critical infrastructure provider, for a total enterprise value of approximately $8.5 billion. The company said it will provide updated full-year 2026 guidance reflecting the deal with its third-quarter results on October 29.
Total enterprise value of approximately $8.5 billion, as stated in the press release.
Agreement to acquire Arcosa was first announced on June 22, 2026.
CRH will issue updated full-year 2026 guidance reflecting the acquisition with third-quarter results on October 29.
The filing furnishes the press release as Exhibit 99.1 under Item 7.01 and does not include new financial results.
CRH reported second quarter 2026 results with total revenues of $10.8 billion, up 6% from the prior year, and net income of $1.5 billion, up 13%. The company reaffirmed its full-year 2026 guidance for net income, Adjusted EBITDA and diluted EPS, and said it has not started a new share buyback tranche while the $8.5 billion Arcosa acquisition is pending.
Q2 2026 diluted EPS was $2.21, up from $1.94 in Q2 2025; Adjusted EBITDA was $2.6 billion, up 7%.
Q2 net income included gains on divestitures; income tax expense rose to $661 million from $425 million.
2026 guidance reaffirmed: net income $3.9 billion to $4.1 billion, Adjusted EBITDA $8.1 billion to $8.5 billion, diluted EPS $5.60 to $6.05.
Capital expenditure guidance was lowered to $2.7 billion to $2.9 billion from $2.8 billion to $3.0 billion; no new buyback tranche has started since the Arcosa agreement on June 22, 2026.
CRH agreed on June 21, 2026 to acquire Arcosa, Inc. through a merger in which Arcosa becomes a wholly owned subsidiary, with Arcosa stockholders to receive $150.00 in cash per share. The deal is expected to close in Q1 2027, subject to Arcosa stockholder approval, regulatory approvals and customary conditions, and CRH plans to fund it with available cash and committed debt financing.
Price of $150.00 per share in cash, a 25% premium to Arcosa's 60-day trading VWAP as of June 18, 2026; enterprise value of approximately $8.5 billion
Termination fee of $371,967,952 payable by Parent in certain regulatory-failure circumstances; $260,377,567 payable by Arcosa in certain circumstances
Outside Date of June 21, 2027, extendable by up to six months if only antitrust or regulatory conditions remain unsatisfied
CRH expects $175 million of run-rate cost synergies by year three and pro forma FY 2026E net debt to Adjusted EBITDA of 2.4x
CRH's board increased its size from 12 to 13 members and appointed W. Anthony (Tony) Will as a non-management director, effective July 1, 2026. Will retired in 2026 as president and CEO of CF Industries Holdings, and the filing describes his board pay as following the standard non-management director program.
Board size increases from 12 to 13 members; Will's appointment is effective July 1, 2026
Will served as president, CEO and board member of CF Industries Holdings from 2014 until his retirement in 2026
Will is currently a director of Union Pacific Corporation and formerly a director of Olin Corporation
Filing states Will has no family relationship with directors or executive officers and no related-party transactions requiring disclosure
CRH appointed Aylwyn Bryan as Chief Financial Officer effective May 12, 2026, replacing Nancy Buese, who stepped down by mutual agreement on May 11, 2026. Bryan has spent 14 years at CRH, most recently as CFO of its Americas Division, and the filing states Buese's departure was not due to any disagreement with the company.
Aylwyn Bryan appointed CFO effective May 12, 2026; he is 47 and has served CRH for 14 years
Bryan's employment agreement sets a base salary of $850,000 and a target bonus of 100% of salary, with a maximum of 200%
Bryan receives an additional long-term equity award of $1,563,000 in connection with his appointment
Nancy Buese remains a non-executive employee through August 11, 2026 and is entitled to separation payments subject to a release of claims
CRH reported first quarter 2026 total revenues of $7.4 billion, up 9% from $6.8 billion a year earlier, and adjusted EBITDA of $0.6 billion, up 18%. The net loss widened to $0.2 billion from $0.1 billion, with diluted loss per share of $0.27 versus $0.15, driven by higher depreciation, impairment charges and interest expense; the company reaffirmed its 2026 guidance.
Total revenues were $7.4 billion, up 9% from $6.8 billion in Q1 2025.
Net loss was $0.2 billion versus $0.1 billion a year earlier; diluted loss per share was $0.27 versus $0.15.
Adjusted EBITDA was $0.6 billion, up 18%; 2026 guidance reaffirmed at net income of $3.9 billion to $4.1 billion and adjusted EBITDA of $8.1 billion to $8.5 billion.
Quarterly dividend of $0.39 per share, up 5%; an additional $0.3 billion share buyback tranche to be completed no later than July 28, 2026.
CRH reported fiscal 2025 results with total revenues of $37.4 billion, up 5%, and diluted EPS of $5.51, up 10%. The company also guided to 2026 net income of $3.9 billion to $4.1 billion and diluted EPS of $5.60 to $6.05, and declared a quarterly dividend of $0.39 per share, up 5%.
FY 2025 total revenues $37.4 billion (up 5%); net income $3.8 billion (up 8%); Adjusted EBITDA $7.7 billion (up 11%)
FY 2025 diluted EPS $5.51, up 10%; diluted EPS pre-impairment $5.57, up 3%
2026 guidance: net income $3.9 billion to $4.1 billion; Adjusted EBITDA $8.1 billion to $8.5 billion; diluted EPS $5.60 to $6.05
Quarterly dividend of $0.39 per share, payable April 8, 2026, to holders of record on March 6, 2026
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every CRH filing is on SEC EDGAR ↗. 8-K briefs of other companies →